Interactions of pulmonary collectins with Bordetella bronchiseptica and Bordetella pertussis lipopolysaccharide elucidate the structural basis of their antimicrobial activities

Infect Immun. 2004 Dec;72(12):7124-30. doi: 10.1128/IAI.72.12.7124-7130.2004.

Abstract

Surfactant proteins A (SP-A) and D (SP-D) play an important role in the innate immune defenses of the respiratory tract. SP-A binds to the lipid A region of lipopolysaccharide (LPS), and SP-D binds to the core oligosaccharide region. Both proteins induce aggregation, act as opsonins for neutrophils and macrophages, and have direct antimicrobial activity. Bordetella pertussis LPS has a branched core structure and a nonrepeating terminal trisaccharide. Bordetella bronchiseptica LPS has the same structure, but lipid A is palmitoylated and there is a repeating O-antigen polysaccharide. The ability of SP-A and SP-D to agglutinate and permeabilize wild-type and LPS mutants of B. pertussis and B. bronchiseptica was examined. Previously, wild-type B. pertussis was shown to resist the effects of SP-A; however, LPS mutants lacking the terminal trisaccharide were susceptible to SP-A. In this study, SP-A was found to aggregate and permeabilize a B. bronchiseptica mutant lacking the terminal trisaccharide, while wild-type B. bronchiseptica and mutants lacking only the palmitoyl transferase or O antigen were resistant to SP-A. Wild-type B. pertussis and B. bronchiseptica were both resistant to SP-D; however, LPS mutants of either strain lacking the terminal trisaccharide were aggregated and permeabilized by SP-D. We conclude that the terminal trisaccharide protects Bordetella species from the bactericidal functions of SP-A and SP-D. The O antigen and palmitoylated lipid A of B. bronchiseptica play no role in this resistance.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Bordetella bronchiseptica / drug effects
  • Bordetella bronchiseptica / pathogenicity*
  • Bordetella pertussis / drug effects
  • Bordetella pertussis / pathogenicity*
  • Cell Membrane Permeability / drug effects
  • Lipopolysaccharides / chemistry*
  • Lipopolysaccharides / metabolism
  • Macrophages, Alveolar / drug effects
  • Macrophages, Alveolar / immunology
  • Phagocytosis / drug effects
  • Pulmonary Surfactant-Associated Protein A / pharmacology*
  • Pulmonary Surfactant-Associated Protein D / pharmacology*
  • Rats

Substances

  • Anti-Bacterial Agents
  • Lipopolysaccharides
  • Pulmonary Surfactant-Associated Protein A
  • Pulmonary Surfactant-Associated Protein D